1. Home
  2. Browse Decisions
  3. F.Supp.2d
  4. 329 F.Supp.2d
  5. 329 F.Supp.2d 1368 (2004)
 

IN RE METOPROLOL SUCCINATE PATENT LIT.

No. 1620, 1:04-80, 1:04-205, 4:03-592, 4:03-1169.

329 F.Supp.2d 1368 (2004)

In re METOPROLOL SUCCINATE PATENT LITIGATION Astrazeneca AB, et al. v. Andrx Pharmaceuticals, LLC, et al., D. Delaware, C.A. No. 1:04-80 Astrazeneca AB, et al., v. Eon Labs, Inc., D. Delaware, C.A. No. 1:04-205 Astrazeneca AB, et al., v. KV Pharmaceutical Co., E.D. Missouri, C.A. No. 4:03-592 Astrazeneca AB, et al., v. KV Pharmaceutical Co., E.D. Missouri, C.A. No. 4:03-1169

Judicial Panel on Multidistrict Litigation.

August 9, 2004.

TRANSFER ORDER

WM. TERRELL HODGES, Chairman.

This litigation consists of two now consolidated Eastern District of Missouri actions and two District of Delaware actions, that are all brought by patent owners AstraZeneca AB, Astra Zeneca LP, and Aktiebolaget Hassle (collectively, "Astra") for infringement of Astra patents relating to TOPROL-XL (R) and its active ingredient (metoprolol succinate).1 These plaintiffs move the...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases